These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 22213637)
1. Functional protease profiling for diagnosis of malignant disease. Findeisen P; Neumaier M Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637 [TBL] [Abstract][Full Text] [Related]
2. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease. Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574 [TBL] [Abstract][Full Text] [Related]
3. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool. Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224 [TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of proteases: tools for granzyme degradomics. van Domselaar R; de Poot SA; Bovenschen N Expert Rev Proteomics; 2010 Jun; 7(3):347-59. PubMed ID: 20536307 [TBL] [Abstract][Full Text] [Related]
6. Proteomic techniques and activity-based probes for the system-wide study of proteolysis. auf dem Keller U; Schilling O Biochimie; 2010 Nov; 92(11):1705-14. PubMed ID: 20493233 [TBL] [Abstract][Full Text] [Related]
7. N- and C-terminal degradomics: new approaches to reveal biological roles for plant proteases from substrate identification. Huesgen PF; Overall CM Physiol Plant; 2012 May; 145(1):5-17. PubMed ID: 22023699 [TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117 [TBL] [Abstract][Full Text] [Related]
9. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745 [TBL] [Abstract][Full Text] [Related]
10. Protease proteomics: revealing protease in vivo functions using systems biology approaches. Doucet A; Overall CM Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712 [TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics and mass spectrometry profiling for cancer detection. Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703 [TBL] [Abstract][Full Text] [Related]
12. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
13. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review. Bakry R; Rainer M; Huck CW; Bonn GK Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433 [TBL] [Abstract][Full Text] [Related]
14. Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS. Neustadt M; Costina V; Kupfahl C; Buchheidt D; Eckerskorn C; Neumaier M; Findeisen P Electrophoresis; 2009 Jun; 30(12):2142-50. PubMed ID: 19582717 [TBL] [Abstract][Full Text] [Related]
15. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181 [TBL] [Abstract][Full Text] [Related]
16. [Clinical proteomics: towards early detection of cancers]. Solassol J; Boulle N; Maudelonde T; Mangé A Med Sci (Paris); 2005; 21(8-9):722-9. PubMed ID: 16115457 [TBL] [Abstract][Full Text] [Related]
17. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246 [TBL] [Abstract][Full Text] [Related]
18. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification. Leung SM; Pitts RL Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311 [TBL] [Abstract][Full Text] [Related]
19. Quantify this! Report on a round table discussion on quantitative mass spectrometry in proteomics. Quadroni M; Ducret A; Stöcklin R Proteomics; 2004 Aug; 4(8):2211-5. PubMed ID: 15274113 [TBL] [Abstract][Full Text] [Related]
20. Disentanglement of protease substrate repertoires. Van Damme P; Vandekerckhove J; Gevaert K Biol Chem; 2008 Apr; 389(4):371-81. PubMed ID: 18208357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]